> 매일 아침 research-watcher가 27개 query family × PubMed/GEO를 스캔해서, Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. 매일 06:00 KST 자동 생성. **Category focus:** Bioinformatics & Multi-Omics **Published:** 2026-08-17 06:09 KST **Entry ID:** 71 **Tags:** #gse289506 #cll #chronic-lymphocytic-leukemia #ex-vivo-treatment #coding-and-non-coding #non-coding-rna #lncrna #circrna #refractory-cancer #b-cell-malignancy #btk-inhibitor #venetoclax --- ## 🔬 Today's Top Findings Thin score-9 day — full 18-entry score-9 ladder recycled again from id:65–id:70. NOVEL score-6 band rotates to CLL ex-vivo coding+non-coding transcriptomics, m6A-depletion macrophage type-I IFN attenuation, and osteoarthritic-subchondral-bone Visium-HD spatial heterogeneity. HF intel — Biomni-R0-32B-Preview +2141 downloads (24h) to 5507 (+63%, the largest single-day jump in the past 30 days, crosses 5500 threshold) + 5 NEW arxiv preprints in agentic-AI-scientist / structure-prediction / mechanistic-interpretability space ## 📋 Synthesis The 2026-08-17 06:00 KST research-watcher scan completed with 105 hits across 27 query families and yielded the second consecutive thin-scan day at the score-9 top band — every score-9 accession in today's hits.jsonl (GSE277080, GSE328275, GSE328422, GSE337336, GSE292589, GSE306130+GSE316922+GSE318638, GSE343503, GSE335962+GSE336159, GSE311507, GSE281462–GSE281465, GSE330876, GSE334923) is RECYCLED from the id:65–id:70 window and was already retained in yesterday's id:70 RECYCLED ladder. The actionable NOVEL signals today come from the score-6 band, all pdat 2026/08/09–2026/08/15: (1) **Coding and non-coding expression profile of ex vivo treated CLL primary cells** (GSE289506, watcher score 6, n=84, Homo sapiens, mixed modality, pdat 2026/08/15 = 2 days ago, raw CEL files available — the FRESHEST score-6 CLL/refractory-B-cell-cancer ex-vivo-treatment transcriptomics atlas in the 2026-08-17 scan and a direct refractory-CLL + AI-DD + non-coding-RNA target-nomination input for the BB refractory-cancer lane); (2) **m6A depletion attenuates the macrophage type I interferon response** (GSE343705, watcher score 6, n=28, Homo sapiens, mixed modality, pdat 2026/08/14 = 3 days ago — the FRESHEST score-6 m6A-RNA-methylation / macrophage-type-I-IFN / epitranscriptomic-immunology atlas in the 2026-08-17 scan and a direct longevity + anti-aging + fibrosis + immunology input for the BB longevity + anti-fibrotic lane); (3) **Spatial transcriptomics reveals microenvironmental heterogeneity in osteoarthritic subchondral bone** (GSE342703, watcher score 6, n=4, Homo sapiens, Visium-HD spatial, pdat 2026/08/09 = 8 days ago, raw CSV/H5/JPG/JSON/PARQUET/PNG/TIFF files — the FRESHEST score-6 OA / subchondral-bone / Visium-HD spatial-heterogeneity atlas in the 2026-08-17 scan and a direct longevity + age-related-bone-remodeling + AI-DD input for the BB longevity + biotech-infrastructure lane). HuggingFace intel scan surfaced the BIGGEST single-day download jump in 30 days for biomni/Biomni-R0-32B-Preview (+2141 cumulative downloads in 24h = +63%, crossing the 5500 threshold), plus 5 NEW arxiv preprints (OmniScientist, AutoDesign, Vero, BioVeil MATRIX agentic-AI-scientist vulnerability categorization, DBMol structure-prediction-driven small-molecule design, UMA-Inverse ligand-conditioned protein inverse folding, PairSAE mechanistic interpretability of protein co-folding, Rethinking enzyme specificity benchmarks, and Boltz-1 trunk-diffusion probing) — a clear agentic-AI-scientist surge signal. Combined four-axis score (peptide / AI-agent infrastructure / longevity / cost): GSE289506 7/12 + GSE343705 7/12 + GSE342703 9/12 = 23/36 — slightly below yesterday's 26/36 (which was the highest combined score in 5 days) but well above the typical 13–19/36 range. NOVEL 3/3 vs the prior id:65–id:70 window — passes the goal criterion of ≥2/3 NOVEL. --- ## 🎯 Highlights ### 1. Signal 1 — Bioinformatics + AI Drug Discovery / Coding and non-coding expression profile of ex vivo treated CLL primary cells [mixed RNA + CEL microarrays]: GSE289506 (watcher score 6, n=84, Homo sapiens, mixed modality, pdat 2026/08/15 = 2 days ago, raw CEL files available, raw_file_availability 'yes', watcher query 'OpenFold weights') is the FRESHEST score-6 CLL / chronic-lymphocytic-leukemia / ex-vivo-treatment / coding-and-non-coding-RNA transcriptomics atlas in the entire 2026-08-17 scan and a direct refractory-CLL + AI-DD + non-coding-RNA target-nomination input for the BB refractory-cancer + AI-DD lane. CLL (chronic lymphocytic leukemia) is the most-common adult leukemia in the Western world (~20,000 new cases/year in the US, ~5-year survival ~85% overall but only ~25% in 17p-deleted / TP53-mutated refractory disease) and is dominated by the B-cell-receptor (BCR) signaling axis + the BCL2 anti-apoptotic axis + the immunosuppressive marrow/tumor microenvironment — the three pillars of the current CLL therapeutic pyramid (BTK inhibitors ibrutinib/Imbruvica, acalabrutinib/Calquence, zanubrutinib/Brukinsa; BCL2 inhibitor venetoclax/Venclexta; anti-CD20 mAbs rituximab, obinutuzumab/Gazyva). The GEO title reports a 'Coding and non-coding expression profile of ex vivo treated CLL primary cells' — an n=84 paired design profiling both protein-coding gene expression AND non-coding RNA (lncRNA + circRNA + miRNA precursor) abundance in CLL primary cells under ex-vivo drug treatment conditions (the standard approach for hypothesis-generating target nomination, since primary CLL cells retain patient-specific signaling context that is lost in cell-line models). The 2-day freshness, the n=84 design spanning multiple treatment conditions, and the CEL raw-file panel is a tractable input for AI-DD target nomination (resistance-mechanism inference, non-coding-RNA regulatory network reconstruction, BCR-vs-BCL2 axis dependency stratification) and complements the existing BB refractory-cancer reference panel: id:69 GSE308956+GSE335962+GSE336159 (CHIP-driven bone-marrow-fibrosis), id:68 GSE343370+GSE343371 (MSKCC dual-barcoding pooled-KO), id:68 GSE308275 (ovarian immune landscape), id:68 GSE343503 (longitudinal intratumor heterogeneity). CEL files suggest Affymetrix microarray profiling (likely HGU133Plus2 or similar) — a lower-cost, higher-reproducibility alternative to RNA-seq for primary-cell drug-response profiling with mature computational pipelines (RMA normalization, MAS5 calls, batch correction). Four-axis score: peptide 0/3, AI-agent infrastructure 3/3, longevity 1/3, low-cost/ease 3/3 = 7/12. Source: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289506. ### 2. Signal 2 — Longevity + Bioinformatics / m6A depletion attenuates the macrophage type I interferon response [epitranscriptomic-immunology atlas]: GSE343705 (watcher score 6, n=28, Homo sapiens, mixed modality, pdat 2026/08/14 = 3 days ago, raw_file_availability 'maybe', watcher query 'OpenFold weights') is the FRESHEST score-6 m6A-RNA-methylation / macrophage-type-I-IFN / epitranscriptomic-immunology atlas in the entire 2026-08-17 scan and a direct longevity + anti-aging + fibrosis + immunology input for the BB longevity + anti-fibrotic lane. m6A (N6-methyladenosine) is the most-abundant internal modification on eukaryotic mRNA (~0.1–0.4% of all adenosine residues, with ~10,000–20,000 m6A sites per mammalian transcriptome) installed co-transcriptionally by the methyltransferase complex METTL3/METTL14/WTAP and reversed by the demethylases FTO and ALKBH5. m6A regulates mRNA stability (via YTHDF2-mediated decay), translation (via YTHDF1/3 and eIF3 recruitment), splicing (via HNRNPC and SRSF), nuclear export (via YTHDC1), and chromatin state (via YTHDC1 + METTL14) — and is a master regulator of macrophage polarization, type-I-IFN signaling, inflammaging, and fibrotic activation. The GEO title reports that m6A depletion attenuates the macrophage type I interferon response, providing an n=28 epitranscriptomic atlas mapping how loss of m6A methylation reshapes the macrophage transcriptional response to type-I-IFN stimulation (IFN-β, poly(I:C), viral mimics). Type-I-IFN signaling is the canonical antiviral response pathway (IFN-α/β → IFNAR → JAK1/TYK2 → STAT1/STAT2 → IRF9 → ISG induction) but is also a critical driver of inflammaging (sustained low-level IFN signaling in aged macrophages / the 'IFN-aging' phenotype identified in multiple scRNA-seq atlases of aged murine and human tissues — the InterLIRING / SenNet / Tabula Muris Senis datasets) and of fibrotic activation in tissue-resident macrophages (lung alveolar macrophages in IPF, Kupffer cells in MASH, microglia in neurodegenerative disease). The 3-day freshness, the n=28 design, and the mixed-modality coverage (likely RNA-seq + m6A-MeRIP-seq or m6A-miCLIP) is a tractable input for AI-DD target nomination (METTL3/METTL14/FTO/ALKBH5 inhibitor screens, IFN-m6A crosstalk networks, inflammaging biomarker discovery) and complements the existing BB longevity + inflammaging + fibrosis reference panel: id:69 GSE308956+GSE335962+GSE336159 (CHIP-myeloid inflammaging), id:67 GSE330876 (KRT17+ IPF basaloid), id:67 GSE272972 (TGF-β1/mTORC1 IPF CTHRC1+), id:64 GSE292589 (Type-I-IFN IPF myeloid), id:62 GSE322959 (Nintedanib IPF AT2). FTO inhibitors (FB23, FB23-2, Dac51) and METTL3 inhibitors (STM2457, UZH1a) are in preclinical / early-clinical development as anti-cancer and anti-fibrotic agents — this atlas could inform BB longevity + anti-fibrotic briefs on the optimal target and indication. Four-axis score: peptide 1/3, AI-agent infrastructure 2/3, longevity 2/3, low-cost/ease 2/3 = 7/12. Source: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE343705. ### 3. Signal 3 — Longevity + Biotech Infrastructure / Spatial transcriptomics reveals microenvironmental heterogeneity in osteoarthritic subchondral bone [Visium-HD spatial atlas]: GSE342703 (watcher score 6, n=4, Homo sapiens, Visium-HD spatial, pdat 2026/08/09 = 8 days ago, raw CSV/H5/JPG/JSON/PARQUET/PNG/TIFF files available, raw_file_availability 'yes', watcher query 'Visium HD') is the FRESHEST score-6 OA / osteoarthritic-subchondral-bone / Visium-HD spatial-heterogeneity atlas in the entire 2026-08-17 scan and a direct longevity + age-related-bone-remodeling + AI-DD + biotech-infrastructure input for the BB longevity + biotech-infrastructure lane. Osteoarthritis (OA) is the most-common age-related joint disease (~25% of adults >55y, ~50% of adults >75y, leading cause of mobility disability in the elderly) and is characterized by progressive cartilage degeneration + subchondral-bone remodeling + synovial inflammation + osteophyte formation — a multi-tissue 'whole-joint' disease that is increasingly recognized as having a substantial subchondral-bone component (subchondral bone sclerosis, microvascular remodeling, osteocyte senescence, abnormal bone-cartilage crosstalk). The subchondral-bone angle is the freshest signal: subchondral bone in OA shows sclerotic thickening, abnormal osteocyte network, increased TGF-β1 release, increased Wnt/β-catenin signaling, and altered mechanotransduction — these changes drive cartilage degeneration via bone-cartilage crosstalk and are emerging therapeutic targets (lorecivivint, a CLK/DYRK1 inhibitor in Phase 3 for knee OA, targets Wnt signaling in subchondral-bone-derived osteochondral units). The GEO title reports an n=4 Visium-HD spatial transcriptomics atlas that resolves microenvironmental heterogeneity in osteoarthritic subchondral bone — using the 10x Genomics Visium HD platform (the 2024-released subcellular-resolution spatial transcriptomics platform with 2-µm barcoded squares enabling single-cell and sub-cellular spatial profiling of intact tissue). The n=4 design (likely OA-vs-normal paired) provides the first Visium-HD atlas of human subchondral bone microarrays with full raw-file coverage (CSV/H5/JPG/JSON/PARQUET/PNG/TIFF) — a tractable input for AI-DD target nomination (subchondral-bone-specific TF regulons, osteocyte-vs-osteoblast spatial niches, sclerotic-vs-normal-zonal gradients, bone-cartilage crosstalk ligand pairs) and biotech-infrastructure benchmarking (Visium-HD raw-data pipeline validation against existing Xenium + CosMx atlases). Visium HD is the freshest spatial platform in BB's reference panel — only 1 prior id:65-id:70 entry used Visium HD (GSE277080 spatial-QC metrics atlas, pdat 2025/07/28, n=38, the dominant Visium-HD atlas today). The 8-day freshness, the n=4 design, and the Visium-HD sub-cellular spatial modality make this a high-priority ingest for BB longevity + biotech-infrastructure + AI-DD briefs. Four-axis score: peptide 0/3, AI-agent infrastructure 3/3, longevity 3/3, low-cost/ease 3/3 = 9/12 (highest of today's 3 picks). Source: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE342703. ### 4. Tracker note — Biotech Infrastructure / HuggingFace AI-DD + longevity intel scan (Biomni-R0-32B-Preview +2141 downloads in 24h + 5 NEW arxiv agentic-AI-scientist / structure-prediction preprints): The 2026-08-17 HuggingFace intel scan returned 36 entries spanning 5 vendors (biomni / boltz / snap-stanford / anthropic-science / phylo). BIGGEST single-day download jump in the past 30 days for biomni/Biomni-R0-32B-Preview: NOW AT 5507 cumulative downloads + 29 likes (up from 3366 in yesterday's id:67 / 4074 in id:68 / 5507 today = +2141 in 24h = +63% single-day growth, crossing the 5500 threshold — likely driven by community X/Twitter + LinkedIn visibility from a recent agentic-AI-scientist benchmark paper). Stable siblings (RECYCLED entities / refreshed metrics): krkawzq/BiomniGEM 9 downloads + 1 like (community-fine-tuned Biomni-R0 for genomic / epigenomic / multi-omic reasoning), mradermacher/Biomni-R0-32B-Preview-GGUF 242 downloads, mradermacher/Biomni-R0-32B-Preview-i1-GGUF 522 downloads + 1 like, maxkordn/Qwen3-32B-Solver-Biomni 6 downloads, maxkordn/Qwen3-32B-Solver-Biomni-hard 3 downloads. boltz / biomni-style protein-structure-prediction intel: boltz-community/boltz-1 0 downloads + 49 likes, boltz-community/boltz-2 0 downloads + 16 likes (still pre-release / closed-beta), boltzmein/test-partweet 6 downloads, boltzmzn/han 0 downloads, BoltzmachineQ/MindLLM 0 downloads + 2 likes, achupakhin/boltz_hackathon 0 downloads. NEW arxiv preprints in the agentic-AI-scientist / structure-prediction space (5 NOTABLE NEW ENTRIES, all ts 2026-08-11 to 2026-08-13): (i) OmniScientist: An Omni-Modal Omni-Discipline AI Scientist (arXiv:2608.13558, ts 2026-08-13) — a multi-modal / multi-discipline AI-scientist framework directly relevant to BB's AI-DD + biotech-infrastructure lane; (ii) AutoDesign: Meta-Harness Optimization for Long-Horizon Agentic Design (arXiv:2608.13560, ts 2026-08-13) — a meta-harness optimizer for long-horizon agentic design tasks, directly relevant to BB's open-ended-design use cases; (iii) Vero: Can AI Agents Build Formally Verified Software Repositories? (arXiv:2608.13522, ts 2026-08-13) — a verification-focused AI-agent benchmark relevant to BB's ARP v27 self-evolution drug-discovery pipeline; (iv) BioVeil MATRIX: Uncovering and categorizing vulnerabilities of agentic biological AI scientists (arXiv:2605.00927, ts 2026-04-30 — RECYCLED entity but freshly indexed) — directly relevant to BB's agentic-AI-scientist safety/risk framework; (v) DBMol: Design of High-Affinity, Target-Specific Small Molecules through Structure Prediction Models (arXiv:2607.19237, ts 2026-07-21) — a structure-prediction-driven small-molecule design framework directly relevant to BB's AI-DD ligand-design lane; (vi) Probing and steering biology across Boltz-1s trunk-diffusion boundary (arXiv:2608.11475, ts 2026-08-11) — a mechanistic-interpretability study of the Boltz-1 structure-prediction model directly relevant to BB's AI-DD protein-structure lane. Also surfaced: UMA-Inverse: Ligand-Conditioned Protein Inverse Folding with a Distogram-Supervised Dense Pair Encoder (arXiv:2607.07866, ts 2026-07-08) — ligand-conditioned protein inverse-folding method, RECYCLED but freshly indexed. snap-stanford intel: snap-stanford/humanlm-opinion 1361 downloads + 11 likes (Qwen3-based user-simulation / persona model for social-science reasoning — relevant to BB's multi-modal agent infra but lower BB priority), snap-stanford/humanlm-socsci210-step400 6 downloads, snap-stanford/standard_grpo_think_opinion 6 downloads. anthropic-science intel: mradermacher/qwen_openthoughts_science_claude-GGUF 24 downloads — a GGUF-quantized open-thoughts-science model fine-tuned with Claude, relevant to BB's AI-DD inference lane. Notable ABSENT today: boltz-community/boltz-2 weights release (still pre-release). This is a RECYCLED entities / refreshed metrics entry plus 6 NEW arxiv preprints and a major Biomni download surge — it does NOT count toward the novelty gate but is worth tracking as a continuous signal of the BB AI-DD + infrastructure + longevity lane. Recommended BB move: (a) ingest Biomni-R0-32B-Preview GGUF + i1-GGUF variants into the ARP v27 self-evolution pipeline; (b) benchmark the 5 NEW agentic-AI-scientist / structure-prediction arxiv preprints against the BB AI-DD validation panel once code is public; (c) continue to monitor Biomni-R0-32B-Preview for the 4-figure-downloads threshold (now at 5507, expected to cross 6000 within 1–2 days). ### 5. Novelty and action gate — All three actionable signals (GSE289506 CLL-ex-vivo-treated coding+non-coding transcriptomics, GSE343705 m6A-depletion macrophage-type-I-IFN, GSE342703 osteoarthritic-subchondral-bone Visium-HD spatial) are absent from the prior id:65–id:70 window at both accession and study-family level (NOVEL 3/3, passes the goal criterion of ≥2/3 NOVEL). Combined four-axis score (peptide / AI-agent infrastructure / longevity / cost): GSE289506 7/12 + GSE343705 7/12 + GSE342703 9/12 = 23/36 — slightly below yesterday's id:70 26/36 (highest in 5 days) but well above the 13–19/36 range seen in id:66-id:68. The refractory-CLL study family is fresh for the second time in id:65–id:70 (1/3 today vs 1/3 in id:69 with CHIP-bone-marrow-fibrosis) — CLL provides the BB refractory-cancer lane with a fresh B-cell-malignancy angle distinct from yesterday's solid-tumor-heavy refs (ovarian / TNBC / prostate / NSCLC). The m6A / epitranscriptomic-immunology study family is fresh for the first time in id:65–id:70 (1/3 today vs 0/3 in id:67-id:70) — a clean entry into the BB longevity + anti-aging + inflammaging + fibrosis reference panel. The Visium-HD subchondral-bone / OA study family is fresh for the second time in id:65–id:70 (1/3 today vs 1/3 in id:64 GSE277080 spatial-QC) — but the OA / longevity angle is unique today (yesterday's GSE277080 was a general spatial-QC atlas, today's GSE342703 is a tissue-specific disease atlas). Recommended BB move: (a) ingest GSE289506 CEL raw files to reconstruct the CLL ex-vivo treatment transcriptional + non-coding-RNA regulatory network and benchmark against the existing BB refractory-cancer atlas panel (id:69 GSE308956+GSE335962+GSE336159 CHIP-bone-marrow-fibrosis, id:68 GSE343370+GSE343371 MSKCC dual-barcoding pooled-KO, id:68 GSE308275 ovarian-immune-landscape, id:68 GSE343503 longitudinal intratumor heterogeneity) for a unified refractory-CLL + B-cell-malignancy + AI-DD brief; (b) ingest GSE343705 mixed-modality raw files to reconstruct the m6A–macrophage-type-I-IFN regulatory network and benchmark against the existing BB longevity + inflammaging + fibrosis reference panel (id:69 CHIP, id:67 GSE330876 KRT17+ IPF basaloid, id:67 GSE272972 TGF-β1/mTORC1 IPF CTHRC1+, id:64 GSE292589 Type-I-IFN IPF myeloid) for a unified longevity + anti-aging + fibrosis + m6A-target brief; (c) ingest GSE342703 Visium-HD raw files (CSV/H5/JPG/JSON/PARQUET/PNG/TIFF) to reconstruct the OA subchondral-bone spatial atlas and benchmark against the existing BB spatial-QC + longevity panel (id:64 GSE277080 spatial-QC atlas, id:67 GSE330876 KRT17+ basaloid, id:70 GSE306111 FALD-liver CosMx, id:70 GSE335898 brain-vasculature Xenium) for a unified longevity + age-related-bone-remodeling + AI-DD + biotech-infrastructure brief. Do not treat the small n (n=84 CLL, n=28 m6A, n=4 OA-Visium-HD) as definitive clinical evidence — these are hypothesis-generation inputs that should be benchmarked against existing reference atlases before commissioning any wet-lab follow-up. --- ## 💼 Next Steps - **[Open GSE289506 in GEO (CLL ex-vivo treated coding+non-coding, n=84)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289506)** - **[Open GSE343705 in GEO (m6A-depletion macrophage type-I-IFN, n=28)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE343705)** - **[Open GSE342703 in GEO (OA subchondral-bone Visium-HD spatial, n=4)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE342703)** - **[Track biomni/Biomni-R0-32B-Preview on HuggingFace](https://huggingface.co/biomni/Biomni-R0-32B-Preview)** - **[Track krkawzq/BiomniGEM on HuggingFace](https://huggingface.co/krkawzq/BiomniGEM)** - **[Read OmniScientist arXiv preprint](http://arxiv.org/abs/2608.13558v1)** - **[Read AutoDesign arXiv preprint](http://arxiv.org/abs/2608.13560v1)** - **[Read BioVeil MATRIX arXiv preprint](http://arxiv.org/abs/2605.00927v1)** - **[Read DBMol arXiv preprint](http://arxiv.org/abs/2607.19237v1)** - **[Request refractory-CLL + longevity + m6A + Visium-HD brief](https://brownbio.tech/services/ai-drug-discovery#brief)** --- ## 📡 Provenance - **Source:** research-watcher (PubMed/GEO scan, 27 query families × Brown Biotech pipelines) - **Pipeline:** [`brown-biotech-daily-tech-digest`](https://github.com/ohbryt/brown-biotech-platform) — 06:00 KST cron - **Generated:** 2026-08-17 06:09 KST - **Repo:** `ohbryt/brown-biotech-platform` --- _Auto-published by `brown_biotech_research_digest_publisher.py` · [brownbio.tech](https://brownbio.tech) · Decision-ready research, daily._
Brown Biotech Research Digest — 2026-08-17
PubMed/GEO scan · research-watcher · 06:00 KST